Abstracts

Notification of acceptance for regular abstract submission were made on Monday, 18 March 2024. If you have questions about abstracts, please contact ISPD Headquarters.

Late-Breaking abstract submission has closed.

Abstracts were accepted under the “late-breaking” category only if they met the following criteria:
  • The research must be new and of sufficient scientific importance to merit special consideration after the standard abstract deadline.
  • Abstracts should describe either large clinical studies or high-impact translational research that could not be completed prior to the regular submission deadline.
  • Clinical studies must be prospective in design.
  • Late-breaking abstracts must not be a revision of an abstract submitted prior to the submission deadline.

Professionals and trainees involved with prenatal diagnosis and therapy were invited to submit an abstract in the "late-breaking" category. Notifications of acceptance were made in late May.

Abstract types are described below and topic categories are listed at the bottom of this page. Abstracts that are presented at the conference will be published in a special edition of Prenatal Diagnosis See Previously Published Abstracts

Presenters of accepted abstracts are expected to register to attend the conference, at least for the day of their presentation. Virtual attendance is available for poster presenters only.

Abstract Types

Submissions are encouraged for the presentation types listed below. Authors may indicate whether they want to be considered for either format, or only for oral presentation. Acceptance for presentation is based on peer review.

Required Sections for Both Types:
Objective, Methods, Results, and Conclusions

Scientific Oral Presentation:
Podium presentation during a plenary session followed by brief Q&A. All oral presentations must be given in person in Boston.

Scientific Poster:
  • In-person presenters: Printed poster as well as a PDF for the virtual platform, with assignment to one of two attended poster sessions on Monday or Tuesday, 8 or 9 July 2024
  • Virtual presenters: PDF and optional video recording, with opportunities to answer questions

 

Topic Categories

Abstract submissions are encouraged in the following categories.

  • Prenatal diagnosis and screening for cytogenomic abnormalities
  • Fetal epigenetics and development
  • Fetal imaging: Ultrasound and Magnetic Resonance Imaging
  • Fetal medical and surgical therapy
  • Global issues in prenatal diagnosis and screening
  • Noninvasive prenatal diagnosis and screening
  • Preimplantation genetic testing
  • Prenatal diagnosis and screening for single gene disorders
  • Reproductive genetic counseling 
  • Prenatal prediction of adverse pregnancy outcomes (e.g., pre-eclampsia / preterm labour / growth restriction and stillbirth)
  • Psychosocial, legal and ethical issues in prenatal diagnosis and fetal therapy
  • Reproductive genomics, metabolomics and proteomics
  • Teratogens and fetal infection
  • Multiple Pregnancy
See Previously Published Abstracts